EMERGENT BIOSOLUTIONS INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$78M
Free Cash Flow↑+4441.2% +$76M
$74M
Investing Cash Flow
$17M
Financing Cash Flow↓-101.0% -$41M
$-400K
Capex↑+129.4% +$2M
$4M
Acquisitions
—
Stock Buybacks
$9M
Stock-Based Comp↑+23.3% +$1M
$5M
Debt Issued
—
Debt Repaid
—
D&A↓-9.6% -$3M
$24M
SBC Allocated Expense↑+23.3% +$1M
$5M